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Abstract
Background: Injections of mixtures prepared from crushed tablets contain insoluble particles
which can cause embolisms and other complications. Although many particles can be removed by
filtration, many injecting drug users do not filter due to availability, cost or performance of filters,
and also due to concerns that some of the dose will be lost.
Methods: Injection solutions were prepared from slow-release morphine tablets (MS Contin®)
replicating methods used by injecting drug users. Contaminating particles were counted by
microscopy and morphine content analysed by liquid chromatography before and after filtration.
Results: Unfiltered tablet extracts contained tens of millions of particles with a range in sizes from
< 5 μm to > 400 μm. Cigarette filters removed most of the larger particles (> 50 μm) but the
smaller particles remained. Commercial syringe filters (0.45 and 0.22 μm) produced a dramatic
reduction in particles but tended to block unless used after a cigarette filter. Morphine was retained
by all filters but could be recovered by following the filtration with one or two 1 ml washes. The
combined use of a cigarette filter then 0.22 μm filter, with rinses, enabled recovery of 90% of the
extracted morphine in a solution which was essentially free of tablet-derived particles.
Conclusions: Apart from overdose and addiction itself, the harmful consequences of injecting
morphine tablets come from the insoluble particles from the tablets and microbial contamination.
These harmful components can be substantially reduced by passing the injection through a
sterilizing (0.22 μm) filter. To prevent the filter from blocking, a preliminary coarse filter (such as
a cigarette filter) should be used first. The filters retain some of the dose, but this can be recovered
by following filtration with one or two rinses with 1 ml water. Although filtration can reduce the
non-pharmacological harmful consequences of injecting tablets, this remains an unsafe practice due
to skin and environmental contamination by particles and microorganisms, and the risks of blood-
borne infections from sharing injecting equipment.
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Background
It is common for many injecting drug users to prepare
injections from tablets that are designed for oral adminis-
tration [1,2]. Tablets contain therapeutically inactive
ingredients to facilitate the lubrication, disintegration and
dissolution of the dosage form [3]. These ingredients
include talc, cornstarch, cellulose, magnesium stearate
and waxes, which are not water soluble and their injection
can cause complications. After injection into any blood
vessel, particles will move downstream until they encoun-
ter a vessel too small to pass, where they lodge forming an
embolism. Blockage of a vessel causes ischemic damage
through a reduction in blood supply to the tissue down-
stream and can result in necrosis of the distal tissue. For
example, injection of particles into a peripheral vein can
lead to pulmonary granulomas, pulmonary oedema,
emphysema and pulmonary fibrosis and hypertension
[4,5]. Smaller particles (< 3-4 μm) can pass through capil-
laries and remain in the circulation until sequestered by
the mononuclear phagocytic system, mainly in the liver
and spleen [6]. Intra-arterial injection, whether deliberate
or accidental, can impair blood supply to a limb and
cause severe tissue ischemia and necrosis, leading to
amputation [7].
Adverse reactions to illicit drug injections are commonly
aggravated by infections due to the non-sterile methods of
preparation and injection procedures. This is seen with
local skin and soft tissue infections, which are the most
common cause of hospital admissions of injecting drug
users [8]. Filterable contaminants in drug injections con-
tribute to many other cardiovascular and infectious com-
plications [9,10].
Although appropriate syringe filters can remove particles
from solutions for injection, their use has not become
routine amongst injecting drug users. While there are
many factors contributing to this, including cost, availa-
bility and performance of syringe filters, one substantial
reason is the concern of many drug users that some of the
drug would be lost in filtration.
The current study was designed to replicate preparation
and filtration methods used by injecting drug users for
injection of slow-release oral morphine tablets (MS Con-
tin®, also known as MST Continus® in some other coun-
tries). This was selected as injection of morphine tablets
was reported as the last drug injected by 15% of the 2270
injecting drug users interviewed in the national 2008 Aus-
tralian Needle and Syringe Program study [11] and as
injected in the past six months by 47% of the 909 frequent
injecting drug users interviewed nationally in the 2008
Illicit Drug Reporting System study [12]. MS Contin is the
morphine tablet most commonly injected [12]. The cur-
rent study aimed to compare the effectiveness of different
types of commonly used filters on their ability to reduce
particle content, and also their effect on amount of mor-
phine remaining in the filtered solution.
Methods
Procedures used by injecting drug users
A survey of injecting drug users in the Hobart area (Tasma-
nia, Australia) presenting to needle and syringe distribu-
tion outlets (n = 260) was conducted to determine the
filtering methods they applied on their last occasion of
morphine injection [13,14]. One-third (29%) had not
used any filter; 41% used cigarette filters (34% hand-roll-
ing cigarette filters); 21% used 0.22 μm syringe filters
accessed through needle and syringe outlets. Minorities
reported use of 0.45 μm syringe filters (2%), cotton balls
(3%), combinations of cigarette and syringe filters (3%)
or other makeshift filters (such as tampons, 1%). Injecting
drug users in the Hobart area (n = 11) subsequently par-
ticipated in detailed interviews to describe how they pre-
pared injections from tablets and their filtration
procedures. The methods used in this laboratory study are
based on these methods.
Extraction of morphine from tablets
One sustained-release 60 mg tablet of morphine sulfate
(MS Contin®, Mundipharma, UK) was wiped with a sterile
swab containing 70% isopropyl alcohol (Briemarpak,
Briemar Nominees, Australia) to remove the orange coat-
ing (replicating the process used by injecting drug users),
then placed on a glass petri dish to dry. The tablet was
then extracted using either cold or hot Water for Injection
BP (Pfizer, Australia). In the cold method, the tablet was
thoroughly crushed using a glass mortar and pestle, and
mixed with 3.0 ml water. The mixture was then stood for
5 min with occasional stirring. Injecting drug users
employ a variety of improvised methods, such as crushing
the tablet between two spoons. However, it was consid-
ered preferable to use a single, reproducible method in
this study, although it is probably more efficient than the
improvised methods and may result in fewer large parti-
cles.
The resulting drug extract was either kept for filtration,
examined for particle content by light microscopy or ana-
lysed for morphine content by high performance liquid
chromatography (HPLC). The mixture was transferred
into a 5 ml plastic specimen tube for particle counting or
a 50 ml volumetric flask for morphine analysis. The effect
of different methods of filtration on the particle and mor-
phine content of the extracts were also examined. Control
solutions were prepared in an identical manner except
that the tablet was omitted.
In the hot method of morphine extraction, the tablet was
crushed by a porcelain pestle in a small (3 cm diameter, 4Harm Reduction Journal 2009, 6:37 http://www.harmreductionjournal.com/content/6/1/37
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cm high), round nickel crucible and the remnants adher-
ing to the pestle were scraped into the crucible. Then 3.0
ml water were added and the crucible placed on a hot
plate and gently boiled, with mixing, for 30-45 s by which
time the mixture appeared to be clear and melted wax
could be seen floating on top. The mixture was then stood
on the bench until it felt cold to touch (about 5 min)
before further treatment as described for the cold prepara-
tions.
It is important to note that cold extraction methods are
recommended by Australian Intravenous Drug Consumer
groups (Network Against Prohibition http://
www.napnt.org/health/filtering_pills.htm; Safer Injecting
Net http://www.saferinjecting.net/injecting-ms-con
tin.htm) due to a perception of loss of active dose follow-
ing hot extraction techniques.
Filtration
Cigarette type filter
A filter used for hand-rolled cigarettes (Ranch Slims, Stu-
art Alexander & Co., Australia) was cut down the side and
the encircling paper removed. Following precisely the
methods reported by injecting drug consumers, the filter
was placed in the drug extraction mixture and moved
around with the tip of a 5 ml syringe (Luer-Lok, sterile, BD
Medical, Melbourne, Australia) until it became saturated
with the liquid. The tip of the syringe was gently pressed
against the side of the filter and the mixture slowly drawn
up. This was repeated at two other sites on the filter, and
the filter usually became blocked before all of the liquid
was drawn up. A second filter was added to enable the fil-
tration to continue until there was no mixture left.
As described for the unfiltered extract, the filtrate was kept
for further filtration, particle counting or morphine anal-
ysis. Two successive 1 ml rinses of water were added to the
mortar or crucible and, after moving the filter around in
the liquid, taken up into the syringe and added to the first
filtrate. With the hot preparation method, each rinse vol-
ume was briefly boiled then cooled before filtration. All
containers were tared and weighed again at different
stages to estimate the volumes collected. Despite the pres-
ence of tablet constituents, it was assumed that the spe-
cific gravity of all the mixtures was that of water to enable
the volumes to be calculated. Aliquots of each rinse were
taken for morphine analysis.
Cotton ball filter
A cotton ball (Home Brand Cotton Balls, Australia) was
cut into four equal parts which were rolled into smaller
balls. One small ball was placed in the drug extraction
mixture and gently moved around with the tip of a 5 ml
syringe to absorb the liquid. The mixture was taken up
into the syringe and treated as described for the cigarette
type filter.
Syringe filter (0.45 or 0.22 μm)
The mixture was taken up into a 5 ml syringe fitted with a
19G needle. The needle was removed and replaced by a
0.45 or 0.22 μm sterile syringe filter (33 mm diameter,
Millex, Millipore, Ireland) and the syringe contents were
slowly pushed through the filter. In some experiments the
filter was flushed with a 1 ml rinse volume of water.
Combined filters
After initial filtration through a cigarette type filter, fol-
lowed by two 1 ml rinses, the combined filtrates were
taken up into a 5 ml syringe and then the needle was
replaced with a 0.45 or 0.22 μm syringe filter and the
syringe contents gently expelled into a container. The filter
was flushed with another 1 ml water.
Analysis of particle content
Glass microscope slides and coverslips were cleaned in
laboratory detergent (Decon 90, Decon Lab., Sussex, UK),
rinsed in tap water, distilled water and methanol, then
dried in air. In some experiments an overnight acid wash
(conc. nitric acid) was included before the water rinses.
A 20 μl aliquot of each sample was pipetted on to a slide
and covered with a 22 × 22 mm coverslip. This volume
filled the area under the coverslip. The slides were viewed
under a light microscope (Gillet and Sibert, London, UK)
in transmission mode. The eyepieces (Leitz Wetzlar, Ger-
many) had reticules which enabled particles of different
sizes to be counted. One eyepiece showed a rectangular
area (360 × 250 μm with 20× objective) and the other a
linear scale (0-10 by 0.1 unit) whose length was 400 μm
with 20× objective. The rectangle and scale were calibrated
using the ruled lines of a Neubauer blood cell counting
chamber (Hawksley, London, UK). Thus the smallest par-
ticle that could be measured with the 20× objective was 4
μm (0.1 on the scale) although smaller particles could be
seen and counted. For each sample, five fields were cho-
sen for counting, at the four corners and centre of the cov-
erslip, selected by moving the microscope stage without
looking through the eyepiece. Particles were counted if
they were inside the rectangle, or overlapped the bottom
or right side, but not if they overlapped the top or left side.
Particles were counted in size groups, using the scale and
a factor based on the magnification of the objective to esti-
mate size. For example, particles 50-99 μm were counted
with the 5× objective, and corresponded to scale readings
0.3-0.5. Particles 20-49.9 μm were counted with the 20×
objective and corresponded to scale readings 0.5-1.24.
Clearly this level of precision was not possible, and bor-
derline particles could have been assigned to either of two
adjacent groups. Total particles in each size group were
estimated from the average count per field multiplied by
the ratio of field area/coverslip area (= number of particles
in 20 μl), then by the ratio of the volume of the injectionHarm Reduction Journal 2009, 6:37 http://www.harmreductionjournal.com/content/6/1/37
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(ml)/0.02 ml to give the number of particles in the injec-
tion mixture. Counts are given as mean ± SD of three rep-
licate preparations. Photomicrographs of slides were
taken with an Olympus BX50 microscope fitted with an
Olympus DP50 digital camera.
Analysis of morphine content
The tablet extract or its filtrate was made to volume (50
ml) with 0.5% acetic acid. About 5 ml was filtered
through a syringe filter consisting of a nylon prefilter and
0.45 μm filter (Chromacol, UK). This step was required to
remove particles before HPLC analysis. The relatively large
volume and acidic pH was expected to maximise the dis-
solution of any morphine that remained in the particles,
and to minimise any retention by the filter. An aliquot of
this filtrate was diluted ten-fold and analysed, in dupli-
cate, by HPLC using a Varian 9010 instrument (Varian,
Australia), a C18 reversed-phase column and UV detec-
tion at 286 nm. The mobile phase was 90% phosphate
buffer (50 mM, pH 3) and 10% methanol, and flow rate
0.7 ml/min. Injections were made using a 20 μl loop.
Standard solutions were prepared from morphine sulfate
BP (British Drug Houses, London, UK) and there was no
internal standard. The retention time of morphine was 4.2
min. Calibration curves from 2.5 - 200 μg/ml were pre-
pared each day and linearity was excellent (r2 > 0.99). As
the morphine content of the tablets is given in mg mor-
phine sulfate, we have done the same with the morphine
recovered from the tablets.
Results
Cold extraction, unfiltered
The outer coating was readily removed with an alcohol
swab and the tablet crushed easily although continued
grinding did not result in an ever-finer powder since the
waxy nature of the powder resulted in some re-compac-
tion.
The crushed tablet suspended in cold water gave an
opaque suspension with a milky appearance (Figure 1).
Macroscopic particles were evident on the wall of the tube.
The mean morphine content (as morphine sulfate) was
56 ± 2 mg from 60 mg tablets (Table 1). Microscopic
examination showed many particles ranging in size from
> 400 μm to < 5 μm (Figure 2A). Particles were not uni-
formly distributed across the coverslip area. Most of the
fields counted were crowded and heterogeneous, making
it difficult to count every particle, and the fields were usu-
ally dissimilar. The larger particles (> 50 μm) tended to be
amorphous in shape and to some extent appeared to be
agglomerations of smaller particles (Figure 2B). In count-
ing the particles, the size group was taken to be that of the
agglomeration, regardless of how friable it appeared. Thus
the assignment of particles to size categories was based on
a subjective judgement of whether they appeared to be
separate or joined. Small particles (< 5-10 μm) sometimes
drifted across the field, and had to be counted quickly
while they remained in view. However, some particles
would have been missed. The smallest particles (< 5 μm)
were generally too numerous to count accurately, and
their counts represent a minimum number.
In some preparations regular crystalline shapes were seen,
with sizes ranging from rectangles of 10 μm × 25 μm, to
rods of 1-2 μm × 5-10 μm (Figure 2C and 2D). Treatment
with weak acid (0.5% acetic acid) dissolved the crystals.
This, together with their shape, and the absence of other
likely candidates in the tablet formulation, suggested that
the crystals were morphine hydrate, which precipitated
because of the alkalinity of the glass. This was confirmed
by examining an extract which gave abundant crystals on
the standard glass slides. The same extract gave no crystals
on either glass slides which had been soaked overnight in
nitric acid, or plastic slides. Because their formation was
considered to be artifactual, the crystals were not included
in the particle count. All slides were examined when
freshly-prepared as crystal formation increased with time
on the slide.
A solution of morphine sulfate 60 mg in 3 ml Water for
Injection had a pH of 4.6. An aliquot (50 μl) was mixed
with an equal volume of 50 mM NaOH, resulting in the
formation of masses of small rods of the same appearance
as those found in the tablet extracts. The cold unfiltered
tablet mixture had a pH of 6.4, which was unchanged after
filtration through the cigarette filter or 0.45 μm or 0.22
μm filters.
Figure 3 shows the number of particles sized 5 μm and
larger in the total injection volume for three preparations:
Injection mixtures (cold extraction) Figure 1
Injection mixtures (cold extraction). Each mixture was 
prepared from one tablet as described in Methods. 1, unfil-
tered; 2, cigarette filtrate; 3, cigarette then 0.45 μm filtrate.Harm Reduction Journal 2009, 6:37 http://www.harmreductionjournal.com/content/6/1/37
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control (no tablet), cold extraction and hot extraction.
Figure 4 shows the additional particles in the smallest size
group (< 5 μm) of the same preparations, plotted sepa-
rately because their counts were an order of magnitude
greater than for the larger particles. The upper panel of Fig-
ure 3 shows the particle counts in unfiltered preparations.
Even in the absence of a crushed tablet, some small (up to
20 μm) particles were found (Control: Unfiltered), reflect-
ing contamination from the local environment. The unfil-
tered cold tablet extract produced a much larger number
of particles of all sizes, with the numbers tending to
increase as the size became smaller (Figure 3, Cold: Unfil-
tered). Although not apparent in Figure 3, there were also
significant numbers of particles in the largest size group (>
400 μm), 12,000 ± 14,000 in the 3 ml injection volume.
The large SD shows the inherent variability of the particle
counts.
Cold extraction, filtered
Two cigarette filters were required to enable the mixture to
be taken into a syringe without the filter being blocked.
The filtrate was milky, like the unfiltered mixture, but it
was also more translucent and there were fewer particles
on the wall of the tube (Figure 1). Only about half (1.7
ml) of the 3 ml water used to prepare the mixture could
be recovered, with the remaining liquid remaining in the
wet filters (Table 1). The mean morphine content of the
filtrate was 32 mg, which is the amount expected to be in
this fraction (1.7/3.0) of the total volume of extract. This
indicates that the morphine was not binding to the filter,
but was being retained because some of the solution was
held up in the filter. Two successive 1 ml rinses with water
recovered most of the remaining morphine (Table 1).
Particles in unfiltered mixture (cold extraction) Figure 2
Particles in unfiltered mixture (cold extraction). Photomicrographs of particles from a single preparation.
100 ȝm A 100 ȝm B
100 ȝm C 10 ȝm DHarm Reduction Journal 2009, 6:37 http://www.harmreductionjournal.com/content/6/1/37
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Some large particles escaped this filtration (Figure 5A),
and there were large numbers of smaller particles and
crystals (Figure 5B). The cigarette filter produced a large
reduction (60-80%) in numbers of particles > 50 μm, a
smaller reduction (10-20%) in particles sized 10-50 μm,
and an increase (20-40%) in the number of smaller parti-
cles (< 10 μm; Figures 3 and 4).
The cotton ball filter gave a similar result to the cigarette
filter: a milky filtrate with limited removal of particles
(data not shown). However, the recovery of morphine
may have been slightly lower (Table 1). Also, it was diffi-
cult to consistently reproduce the size and density of the
filters.
The 0.45 μm syringe filter gave a clear solution (Figure 1),
but the filter tended to block and it required considerable
pressure to deliver the last of the filtrate. Additionally, the
volume of filtrate was low (1.9 ml), containing only 34
mg morphine. However, this was the amount expected for
the fraction of mixture which was filtered. The filtrate was
relatively particle-free, and this will be described under
the combination filtration procedure.
Hot extraction, unfiltered
The tablet could only be coarsely crushed in the crucible,
but everything melted or went into solution when the
water was boiled. Care was taken to minimise evaporative
water loss, since this tended to increase crystal formation.
On cooling, the mixture became turbid and some large
waxy solids separated. The largest masses were not taken
up into the syringe and were therefore not included in the
particle count. The aspirated mixture had a milky appear-
ance, similar to that produced by cold extraction. The
morphine extraction (59 ± 1 mg, Table 2) was virtually
complete. Microscopic examination showed that, com-
pared to cold extraction, there were fewer particles sized
10 μm or larger, and more sized less than 10 μm (Figures
3 and 4). However, the injection still contained an average
50,000 particles in each of the size groups 50-99 μm and
> 100 μm. Figure 6A shows a field with one very large par-
ticle (> 400 μm) and many smaller particles, and panel B
shows what appear to be solidified droplets of melted
wax. The microscopic appearance of hot extractions was
characterised by droplets, particles, and crystals (Figure 6A
and 6D). The larger droplets had inclusions, either parti-
cles or other droplets. The formation of many small drop-
lets contributed to the large number of small particles
present.
Hot extraction, filtered
Aspiration through a cigarette filter removed all of the
largest particles (> 100 μm) but only 10-50% of the
smaller particles (Figures 3 and 4). In preliminary experi-
ments it was found that, if the mixture was still warm,
many more of the wax droplets passed through the filter.
Table 1: Recovery of morphine after cold extraction and filtration
Filtration Volume of extract
(ml)
Amount of morphine
(mg)
P versus cig.
filter alone*
None 3.0 55.8 ± 1.9
(N = 4)
Cigarette filter
First filtrate 1.7 ± 0.1 31.7 ± 2.3
First rinse 1.1 ± 0.0 12.8 ± 0.7
Second rinse 1.1 ± 0.1 5.9 ± 0.2
Total 3.9 ± 0.1 50.5 ± 1.8
Cotton wool
First filtrate 1.7 ± 0.1 30.5 ± 1.9
First rinse 1.1 ± 0.1 10.6 ± 1.2
Second rinse 1.0 ± 0.0 5.0 ± 0.8
Total 3.8 ± 0.0 46.1 ± 0.1 0.099
0.45 μm filter 1.9 ± 0.0 33.9 ± 1.0 0.098†
Combined filtration
Cig.+ 0.45 μm filter 5.0 ± 0.2 51.5 ± 0.7 0.701
Cig. + 0.22 μm filter 4.9 ± 0.2 51.9 ± 1.4 0.410
Data are mean ± SD, N = 3 except where otherwise indicated.
*This figure provides a comparison of the amount of morphine recovered through use of the target filter to that recovered through use of a 
cigarette filter. Comparisons were made by Mann-Whitney U test (a non-parametric analogue of the t-test), 2-tailed. Results are consistent with 
parametric analysis with Games-Howell post-hoc tests with the exception of †0.45 μm filters (p < 0.05). P values greater than 0.05 suggest that it is 
unlikely that there is any real difference between the amount of morphine recovered in the two compared techniques.Harm Reduction Journal 2009, 6:37 http://www.harmreductionjournal.com/content/6/1/37
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As with the cold preparation, nearly all of the dose could
be recovered after 2 × 1 ml rinses with water (Table 2).
Filtration through cotton wool balls gave no better recov-
ery of morphine (Table 2) and, because of the variability
in forming these filters, was not further considered.
The 0.45 μm syringe filter again gave a clear solution with
recovery of 41 mg morphine, which increased to 52 mg
after a 1 ml rinse (Table 1). The particle count is described
after combination filtration.
Combination filtration
Fresh extracts were prepared using cold and hot water and
passed sequentially through a cigarette filter then syringe
filter (0.45 μm or 0.22 μm), with rinses. After both cold
and hot extraction with cigarette filtration, the subsequent
syringe filtration step did not significantly reduce the
recovery of morphine (Tables 1 and 2). Both syringe filters
Particles 5 μm or larger in injection mixtures Figure 3
Particles 5 μm or larger in injection mixtures. Numbers of particles (in thousands) estimated to be in the total injection 
volumes, prepared without a tablet (control) or with cold or hot extraction. Upper panel, unfiltered; lower panel, cigarette fil-
trate. Total injection volumes are given in Table 1. Values are mean ± SD (N = 3).
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Hot Extract: Cig. Filtrate
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Particles less than 5 μm in injection mixtures Figure 4
Particles less than 5 μm in injection mixtures. Num-
bers of particles (in thousands) estimated to be in the total 
injection volumes. The unfiltered extracts were passed suc-
cessively through a cigarette filter then a syringe filter (0.45 
μm or 0.22 μm). Values are mean ± SD (N = 3).
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greatly reduced the particle count, to levels at or below the
control counts (Figures 7 and 4). In some samples (e.g.
0.45 μm filtrate after hot extraction) there appeared to be
large numbers of small (< 5 μm) particles or droplets.
However, this will require confirmation by re-investiga-
tion using cleaner conditions.
Discussion
Morphine in the MS Contin® slow-release tablet is embed-
ded in a complex dual matrix of hydroxyethyl cellulose
and cetostearyl alcohol, designed to release the drug over
12 h [15]. Crushing the tablet disrupts this matrix, allow-
ing the rapid extraction of morphine. The amount of mor-
phine in prolonged-release tablets is permitted to vary by
5% [16] so a 60 mg tablet could contain from 57 to 63 mg
morphine sulfate. The extraction of morphine by cold
water (56 mg) and hot water (59 mg) was therefore essen-
tially complete. None of the filters bound morphine, and
their retention of morphine was due to the volume of liq-
uid which remained. Consequently, rinsing the filters
increased the recovery of morphine. Repeated rinses
brought diminishing recoveries of morphine, and
increased the volume to be injected, and therefore the
number of rinses used in the combined filtration method
was a minimized but nevertheless gave a good recovery
(84-93%) of the extracted morphine. Overall, the extrac-
tion of morphine and its recovery after filtration was sim-
ilar after cold and hot extraction.
The MS Contin® tablet contains a number of constituents
with low or no water solubility which are liable to pro-
duce particles in the extract [17]. These include cetostearyl
alcohol, which is a mixture of two waxes: cetyl alcohol (1-
hexadecanol, mp 49°C) and stearyl alcohol (1-octadeca-
nol, mp 61°C); magnesium stearate (mp 88°C); talc, a
hydrated magnesium silicate; and hydroxyethylcellulose
(a gelling agent which is insoluble in water). The coating
contains other insolubles such as iron oxide, but this was
usually removed in preparing the extracts.
There are advantages and disadvantages in counting parti-
cles by microscopy rather than an instrumental method,
such as the Coulter Multisizer which has been used to
study the effectiveness of filters for heroin injections [18].
In this latter study, the instrument required considerable
dilution of the sample (50 μl to 75 ml) with the possibil-
ity of dissolution of some particles which would have
been present in the smaller volume to be injected. The
dilution was made with an electrolyte (saline) which may
also have affected particle solubility or aggregation.
Microscopy avoided dilution and enabled examination of
the appearance of particles, which gave insights into their
origin (such as crushed solids, condensed wax droplets,
and crystallised morphine) which in turn can indicate
how they could be removed. However, microscopy neces-
sarily examines only a small part of the total sample, add-
ing to errors as discussed below.
Counting particles, especially in the unfiltered prepara-
tions, was inherently variable due to the large amount of
insoluble material and its complex physical form. This
variability also affected instrumental counting, and Scott
[18] considered that variability in the particle counts
made the exact values meaningless although useful for
comparison of filters. In our study counts are presented as
the number of particles in an injection volume in order to
relate the data to health impacts. This required a large
multiplier factor. For example a count of one 100 μm par-
Particles in cigarette filtrate (cold extraction) Figure 5
Particles in cigarette filtrate (cold extraction). Photomicrographs of particles from a single preparation.
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ticle in 5 fields using the 5× objective would give an esti-
mated 8,897 particles in the 3 ml dose volume, and one
10 μm particle (20× objective) would give 161,333 parti-
cles in 3 ml. If there were no similar particles in the other
two replicate mixtures, then the mean particle counts
would be 2966 for the 100 μm particle and 53778 for the
10 μm particle. The particle counts are therefore reported
in thousands to avoid implying a level of precision which
would be misleading. The counts are indicative estimates
rather than precise determinations, but are nevertheless
able to show that filtering can greatly reduce the number
of particles injected.
The working area for preparing the injections was neither
sterile nor particle-free, since the aim was to reproduce the
typical conditions used for illicit preparations by injecting
drug users. Consequently, a significant number of parti-
cles and fibres were found when control injections were
prepared, showing that particles are ubiquitous unless
removed by specific cleaning procedures. Fibres, however,
were not counted as particles since they were present on
control slides and were not considered to be tablet-
derived. Environmental particles will vary widely accord-
ing to local conditions but will add to the total particle
burden in the injection. Not using a clean workplace
became a limitation in counting particles in the cigarette
plus 0.22 μm filtrate, in which virtually all tablet-derived
particles had been removed.
The form of the waxes was evidently altered after melting
and re-solidifying, with the formation of wax droplets of
various sizes. Hot extraction resulted in a shift in particle
size distribution, with the formation of more small parti-
cles (< 5 μm) and fewer larger particles. However, the
remaining particle burden in unfiltered preparations was
still too large for this to be considered other than harmful
Particles in unfiltered mixture (hot extraction) Figure 6
Particles in unfiltered mixture (hot extraction). Photomicrographs of particles from a single preparation.
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to inject. Pharmaceutical standards require that, measured
by microscopy, injections of less than 100 ml must have,
in total, no more than 3000 particles > 10 μm and no
more than 300 particles > 25 μm [16]. The hot unfiltered
morphine tablet preparations had, in the total volume of
3 ml, an average 1.1 million particles > 10 μm and
368,000 particles > 20 μm. For the cold preparations, the
numbers of particles were 7.2 million > 10 μm, and 4.0
million > 20 μm.
The aqueous solubility of morphine is critically depend-
ent on its ionization and therefore the pH, as the ionized
form is freely soluble and the free base has a low water sol-
ubility (0.25 mg/ml at 35°C) [19]. These authors found
that, at 35°C, the solubility of morphine in water was
13.39 mg/ml at pH 6.35 and 5.75 mg/ml at pH 6.69. This
change in solubility with pH could be explained by the
change in ionization and the low free base solubility. A 60
mg tablet of morphine sulfate (MW = 758.9) contains
45.1 mg morphine (MW = 285.3), or 15.0 mg/ml in the 3
ml extract. Using the amount of morphine sulfate recov-
ered in cold extracts, this concentration would be 14.0
mg/ml. In either case, the concentration of morphine in
the 3 ml extract will be critically close to, or exceed, its sol-
ubility, especially as the pH is slightly higher (6.4) and the
temperature was considerably lower (about 20°C). From
the pKa of morphine (8.08) and the buffer equation, pH
= pKa + log10([base form]/[acid form]), it can be calcu-
lated that morphine is 1.8% unionized at pH 6.35 and
2.1% unionized at pH 6.40.
It was considered that morphine crystal formation was an
artifact due to alkalinity in the glass microscope slide or
cover, since they did not form on acid-washed glass or
plastic slides. However, there is a significant risk of forma-
tion of morphine crystals in the tablet extracts,, and con-
ditions of preparation could reduce this problem by
decreasing pH or, preferably, increasing the volume of
water. Although morphine will eventually dissolve in
blood this will take some time, and any crystals which
remain undissolved during the brief transit time from
injection site to capillary bed are liable to cause embo-
lisms.
The unfiltered tablet extracts must be considered
extremely harmful as they contained many particles of all
sizes. After intravenous injection, particles will flow
through ever-widening vessels back to the heart and then
they will enter the pulmonary circulation, where the
smaller arteries which are 300-400 μm diameter [20]
could be occluded by the largest particles found in unfil-
tered mixtures. Arterioles (9-40 μm diameter) and capil-
laries (7-9 μm diameter) could be blocked by the smaller
particles. Even particles too small to embolize may cause
vascular injury. Small airborne particles (< 2.5 μm) have
been implicated in cardiac and vascular damage, includ-
Table 2: Recovery of morphine after hot extraction and filtration
Filtration Volume of extract
(ml)
Amount of morphine
(mg)
P versus cig.
filter alone*
None 3.0 58.9 ± 1.3
Cigarette filter
First filtrate 2.1 ± 0.1 42.4 ± 0.9
First rinse 1.0 ± 0.1 9.1 ± 1.9
Second rinse 1.1 ± 0.1 2.7 ± 0.1
Total 4.1 ± 0.1 54.3 ± 2.6
Cotton wool
First filtrate 1.6 ± 0.2 35.3 ± 4.4
First rinse 1.1 ± 0.0 12.1 ± 2.3
Second rinse 1.0 ± 0.2 5.2 ± 0.6
Total 3.8 ± 0.3 52.6 ± 3.1 0.393
0.45 μm filter
First filtrate 1.9 ± 0.2 41.2 ± 2.3
Rinse 0.9 ± 0.1 10.7 ± 2.4
Total 2.8 ± 0.2 51.8 ± 1.9 0.203
Combined filtration
Cig.+ 0.45 μm filter 4.5 ± 0.3 52.4 ± 1.6 0.400
Cig. + 0.22 μm filter 4.3 ± 0.6 49.6 ± 2.0 0.096
Data are mean ± SD, N = 3.
*Comparison of morphine recovery by Mann-Whitney U test (a non-parametric analogue of the t-test), 2-tailed. Results are consistent with 
parametric analysis with Games-Howell post-hoc tests.Harm Reduction Journal 2009, 6:37 http://www.harmreductionjournal.com/content/6/1/37
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ing endothelial dysfunction and promotion of atheroscle-
rotic lesions [21]. Large numbers of particles of this size
were present in the unfiltered mixtures.
The cigarette filter reduced the number of particles, espe-
cially the larger particles. This filter was more effective
when used after hot extraction, but the remaining particle
burden remained too high for injection. Of course, ciga-
rette filters are not designed for liquids. The morphine
recovery from the cigarette filters was nearly complete
(90%) after two rinses. The unfiltered mixtures caused a
block of the syringe filters, but the cigarette filtrate passed
through them, as did the rinse volumes. Scott [18] found
that both 0.22 μm and 0.45 μm syringe filters blocked
with heroin injections, and abandoned them in favour of
5 μm filters. However, these blockages can be prevented
by the use of a preliminary, coarse filter, such as the ciga-
rette filter applied here.
The combination of cigarette filter then syringe filter
mostly gave a good recovery of the extracted morphine.
The 0.22 μm filter is considered to be sterilizing because,
unlike the 0.45 μm filter, it will remove bacteria. In a trial
with injecting drug users [22], it was found that 0.22 μm
syringe filters were effective in removing bacteria from 3
out of 4 injections, while larger pore filters (15 - 20 μm)
were completely inadequate.
Conclusions
When a tablet of slow-release morphine (MS Contin®) is
crushed and mixed with water, the resulting mixture con-
tains millions of particles, of sizes from less than 5 μm to
greater than 400 μm. These particles will cause great harm
if injected into the bloodstream. The number of particles
can be greatly reduced by filtration. A low-porosity syringe
filter (0.45 or 0.22 μm) is most effective, but is likely to
block unless a coarser filter is used first. Little of the mor-
phine is lost in filtration if the filters are rinsed.
Hot extraction does not significantly increase extraction of
morphine, and carries the risk of filtering a warm mixture
which allows wax to pass through the filter, producing
particles when it cools and solidifies. In practice, it is
uncommon for solutions to be left for long before filtra-
Particles 5 μm or larger in syringe filtrates Figure 7
Particles 5 μm or larger in syringe filtrates. Numbers of particles (in thousands) estimated to be in the total injection vol-
umes, prepared without a tablet (control) or with cold or hot extraction. Upper panel, 0.45 filtrate; lower panel, 0.22 μm fil-
trate. Total injection volumes are given in Table 1. Values are mean ± SD (N = 3).
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tion and injection, producing the potential for a substan-
tially greater level of filtrate contamination with wax than
identified in the current study.
It is not possible to prepare an injection of pharmaceutical
standard without clean facilities, as some particles will
remain even after filtration through a syringe filter, and
the injection will not be sterile. Also, the manufacturer
cautions against using Millex® sterile filters for suspen-
sions or emulsions, because they are not designed for this
purpose (Millipore Millex User Guide, 2008). However,
filtration with a 0.45 μm or 0.22 μm filter can remove vir-
tually all of the tablet-derived particles and should be a
standard method of harm reduction for injecting drug
users (a plain language summary of this study is provided
in Additional file 1 in order to facilitate health interven-
tions). The 0.22 μm filter is to be preferred, as it can
remove the organisms (e.g. Staphylococcus aureus, Candida)
which commonly produce cutaneous and systemic infec-
tions in injecting drug users [7,8,10]. Although it cannot
remove the much smaller virus particles, including Hepa-
titis C [23], viral infections are mostly due to blood con-
tamination from shared equipment and are avoided by
not sharing. In one Canadian hospital, the two most com-
mon reasons for admission of injecting drug users were
pneumonia and soft-tissue infections [24], both poten-
tially preventable by effective skin swabbing and filtration
of injections. The average daily cost of hospitalization was
$CAN610 ($USD420 at the time of the study), which
makes the use of alcohol swabs (currently <$USD0.02 in
Australia) and filters (<$USD0.90) extremely cost-effec-
tive.
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